Skip to content

Clinical trials

Purpura, Thrombocytopenic, Idiopathic trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Country / region: United Kingdom Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20081
20091
20101
20122
20145
20152
20174
20182
20191
20205
20216
20224
20234
20241
20256
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Terminated8
Recruiting7
Active, not recruiting5
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
argenx7
Novartis Pharmaceuticals6
GlaxoSmithKline4
Amgen3
UCB Biopharma SRL3
Bioverativ, a Sanofi company2
Pfizer2
Principia Biopharma, a Sanofi Company2
Protalex, Inc.2
Rigel Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic50
Thrombocytopenia8
Purpura6
Blood Platelet Disorders4
Autoimmune Diseases3
Hematologic Diseases3
Hemorrhage3
Immune System Diseases3
Anemia, Hemolytic, Autoimmune2
Cytopenia2

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.